insights_auto
Why is NOVOB80 up २.३३%?
Dive Deeperchevron_right
NOVOB80:BKK
NOVOB80 KTB DR
฿ १.३२
arrow_upward
+२.३३%(+०.०३०) 1D
अक्टोबर १६, ०२:५५:३० GMT+७ · THB
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NOVOB80...
Open
฿ १.२८
High
฿ १.३०
Low
฿ १.२७
Mkt. cap
१.३२ खरब
Avg. vol.
३८.८२ लाख
Volume
४३.५२ लाख
52-wk high
฿ २.०२
52-wk low
฿ १.१२
Shares outstanding
३.०० अरब
No. of employees
६७ हजार
Open
฿ १.२८
High
฿ १.३०
Low
฿ १.२७
Mkt. cap
१.३२ खरब
Avg. vol.
३८.८२ लाख
Volume
४३.५२ लाख
52-wk high
฿ २.०२
52-wk low
฿ १.१२
Shares outstanding
३.०० अरब
No. of employees
६७ हजार
News stories
From web sources and news partners
The Motley Fool
·
५ घण्टा पहिले
Novo Nordisk and Eli Lilly Just Got Some Fantastic News
Traders Union
·
१४ घण्टा पहिले
Novo Nordisk shares technical analysis: Buyer support underpins upward price move
Foreign Policy Journal
·
२० घण्टा पहिले
Novo Nordisk (NYSE: NVO) Stock Price May Be 63% Undervalued As Buyback And Pipeline Catalysts Mount
TradingKey
·
१ दिन पहिले
Novo Nordisk A/S Stock (NVO) Moved Up by 3.38% on Oct 15: What Investors Need To Know
Profile
Novo Nordisk A/S, doing business as Novo, is a Danish multinational pharmaceutical company. Novo manufactures and markets pharmaceutical products and services, primarily diabetes and obesity medications and devices. The corporation was created in 1989, through a merger of two Danish pharmaceutical companies, which date back to the 1920s.
Novo employs approximately 68,800 people in 80 countries, and markets its products in approximately 170 countries. Novo is controlled by majority shareholder Novo Holdings which holds 28% of its shares and a majority of its voting shares.
Novo is a full member of the European Federation of Pharmaceutical Industries and Associations.
The company was ranked 25th among Fortune's 100 Best Companies to Work For in 2010, and subsequently ranked 72nd in 2014 and 73rd in 2017. In January 2012, Novo was named the most sustainable company in the world by the business magazine Corporate Knights. It is a leader in the FTSE4Good Index, and the only European company in the top ten.
Novo is the largest pharmaceutical company in Denmark. In 2023, Novo's market capitalization exceeded the GDP of Denmark, and it became the highest valued company in Europe. Wikipedia
About NOVOB80 KTB DR
CEOMaziar Mike Doustdar
Employees६६.७ हजार
Founded१९२३
HeadquartersBagsværd, Capital Region of Denmark, डेनमार्क
Sector-
Websitenovonordisk.com